This event will discuss the payer and HTA agencies’ challenges in budget management and cost-containment, compared to their enthusiasm to reimburse expensive treatments and diagnostics. This is the ideal event for those looking to find out novel methods and ideas for achieving patient access to advanced pharmaceuticals and devices in one of the world’s most advanced regions.

The Nordic healthcare systems are some of the most advanced and well-funded in the world and typically achieve world-class health outcomes. Nordic countries (Sweden, Denmark, Norway, Finland, Iceland) share a similar culture, all are considered rich economies and are all dedicated to high levels of public healthcare investment. Apart from this, the countries also differ in many respects, such as Norway not being a member of the EU and only Finland is a member of the Euro currency. Whilst relatively wealthy countries, all are increasingly facing challenges in terms of ageing populations and limited resources, so cost-containment is increasingly necessary. Across the region, healthcare systems are also far from homogenous, with different methodologies for valuing expensive drugs and devices, and different centralized vs. decentralized approaches to managing healthcare systems and spending. There are also broad differences between drugs and medical devices in terms of the necessity for and method of conducting Health Technology Assessment (HTA).

There are often rigorous assessments for drugs to determine clinical and economic value, whilst device “value” is often overlooked vs. cost, especially in more rigid DRG systems and tendering processes. Nordic countries are often rich in accurate, real world, patient-level data, with huge, national-level patient registries, tracking specific patients their whole lives. Advanced Electronic Medical Record (EMR) systems are increasingly allowing better access to that data, however privacy and transparency concerns are real challenges. Better access to accurate evidence can facilitate the accurate measurement of improved health outcomes.

This event will discuss the payer and HTA agencies’ challenges in budget management and cost-containment, compared to their enthusiasm to reimburse expensive treatments and diagnostics. Participants will learn how drugs and technologies of high clinical and economic benefit will be assessed by payers, and how they can further develop, measure, demonstrate and deliver this value to health systems. This is the ideal event for those looking to find out novel methods and ideas for achieving patient access to advanced pharmaceuticals and devices in one of the world’s most advanced regions.

Payers, HTAs & Policy Makers

Head of Unit
TLV, Sweden

Head of Section, Health Economics
Amgros, Pharmaceutical Procurement Service for Regional Authorities, Denmark

Strategic Advisor, Pharmaceuticals
Amgros, Denmark

Professor and Program Manager
SBU, Sweden

Project Manager
Swedish Association of Local Authorities and Regions, Sweden

CEO
National Swedish Pharmaceutical Insurance, Sweden

CEO
sundhed.dk – the Danish eHealth Portal, Denmark

Deputy Secretary General for E-services and Innovation
Ministry of Social Affairs, Estonia

Medical Director
Norwegian Medicines Agency, Norway

Principal Pharmaceutical Officer, Pharmaceuticals Pricing Board
Ministry of Social Affairs and Health, Finland

Director of Research and Education, Professor in Medical Biophysics
Region Jämtland Härjedalen, Östersund, Sweden

 

Pharma Industry

Head External Affairs
Swedish Pharma Association (LIF), Sweden

Nordic Real-World Evidence Lead
Novartis, Sweden

Market Access and Pricing Manager
Lundbeck, Denmark

European Market Access and Pricing Director
GSK, Denmark

Market Access Lead
Bristol-Myers Squibb, Sweden

Value & HTA Lead, Nordics
Bristol-Myers Squibb, Sweden

 

MedTech Industry

Program Director
Medtech4Health, Sweden

Health Economy & Government Affairs Manager Nordic, Boston Scientific
Project Manager for the Nordic Medtech Growth2, Medtek, Norway

Chief Medical Officer
IBM Nordic, Denmark

COO and deputy CEO
Brighter AB, Sweden

Commercial Development Director
Essilor, Denmark

ICT Project Manager
Medtech4Health, Sweden

 

Academics & Advisors

Deputy Chief Executive (DCE)
Herlev and Gentofte Hospital, University of Copenhagen, Denmark

Partner
Advokatfirman Delphi, Sweden

Managing Director Science & Policy
Faculty of Health Sciences, University of Southern Denmark
Former EUnetHTA Executive Committee Chairman and EUnetHTA Secretariat Director

 

Expert Solution Providers

CEO
Synergus AB, Sweden

Pictures from recent pharma and medtech market access events. Imagine being there...

Speaker List - Day 1

Head External Affairs
Swedish Pharma Association (LIF), Sweden

Head of Unit
TLV, Sweden

Professor and Program Manager
SBU, Sweden

Head of Section, Health Economics
Amgros, Pharmaceutical Procurement Service for Regional Authorities, Denmark

Deputy Chief Executive (DCE)
Herlev and Gentofte Hospital, University of Copenhagen, Denmark

Medical Director
Norwegian Medicines Agency, Norway

Principal Pharmaceutical Officer, Pharmaceuticals Pricing Board
Ministry of Social Affairs and Health, Finland

CEO
National Swedish Pharmaceutical Insurance, Sweden

CEO
sundhed.dk – the Danish eHealth Portal, Denmark

Deputy Secretary General for E-services and Innovation
Ministry of Social Affairs, Estonia

Speaker List - Day 2, Stream 1

CEO
Synergus AB, Sweden

European Market Access and Pricing Director
GSK, Denmark

Nordic Real-World Evidence Lead
Novartis, Sweden

Partner
Advokatfirman Delphi, Sweden

Market Access Lead
Bristol-Myers Squibb, Sweden

Value & HTA Lead, Nordics
Bristol-Myers Squibb, Sweden

Market Access and Pricing Manager,
Lundbeck, Denmark

Strategic Advisor, Pharmaceuticals
Amgros, Denmark

 

Speaker List - Day 2, Stream 2

Project Manager
Swedish Association of Local Authorities and Regions,Sweden

Director of Research and Education, Professor in Medical Biophysics
Region Jämtland Härjedalen, Östersund, Sweden

Program Director
Medtech4Health, Sweden

ICT Project Manager
Medtech4Health, Sweden

Health Economy & Government Affairs Manager Nordic Boston Scientific
Project Manager for the Nordic Medtech Growth2 Medtek, Norway

COO and deputy CEO
Brighter AB, Sweden

Commercial Development Director
Essilor, Denmark

Partner
Advokatfirman Delphi, Sweden

Chief Medical Officer
IBM Nordic, Denmark

This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

PAYERS, HTAs & POLICY MAKERS:
Senior representatives from Payers, health plans & insurers, Public health experts, health technology assessors, hospital financial management, government & health ministry officials, health management and managed care organizations, epidemiology, horizon scanning, scientific advice, pharmacy strategy & budget management.

PHARMA & MEDTECH INDUSTRY: Corporate senior management, vice presidents, directors, senior managers in:
Market access, health economics, pricing & reimbursement, health outcomes, real-world evidence, government & regulatory affairs as well as those focused on designing studies to achieve value-adding endpoints, such as R&D strategy, clinical development, digital health, and medical affairs.

OTHER STAKEHOLDERS:
Regulatory agencies, key-opinion leaders, independent health economists, health researchers and academics, physicians, patient groups, consultants & solution providers.

EVENT PARTNERS

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Share with Colleagues